Sign in
4

Changes in Ownership

RECURSION PHARMACEUTICALS, INC. Filed Acc 0001209191-23-059032

Director sold 20,141 shares at $9.00 ($181,269)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Dar Zavain · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-12-14 Sale : show line 1 in the form 10b5-1 −20,141 $9.00 $181,269 53,823 D
Open-market sales · 20,141 sh · avg $9.00 · $181,269
Loading xslF345X05/doc4.xml…